RASRx Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
RASRx General Information
Description
Developer of an oral therapy designed to improve muscle strength and regeneration, with decreased muscle inflammation and fibrosis. The company's therapy has shown positive effects on muscle function in an MDX mouse model and potentially reverses disease progression to bring relief to patients, and possibly other muscular dystrophies, enabling physicians with complex muscle pathology to treat Duchenne muscular dystrophy.
Contact Information
Website
www.rasrx.comCorporate Office
- 231 Bonetti Drive
- Suite 240
- San Luis Obispo, CA 93401
- United States
Corporate Office
- 231 Bonetti Drive
- Suite 240
- San Luis Obispo, CA 93401
- United States
RASRx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 16-Aug-2022 | Completed | Out of Business | |||
2. Early Stage VC | 06-Jan-2016 | Completed | Generating Revenue | |||
1. Grant | 11-Nov-2015 | $1M | Completed | Generating Revenue |
RASRx FAQs
-
When was RASRx founded?
RASRx was founded in 2014.
-
Where is RASRx headquartered?
RASRx is headquartered in San Luis Obispo, CA.
-
What industry is RASRx in?
RASRx’s primary industry is Drug Discovery.
-
Is RASRx a private or public company?
RASRx is a Private company.
-
What is RASRx’s current revenue?
The current revenue for RASRx is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »